Patents Assigned to Apoxis SA
  • BAFF receptor (BCMA), an immunoregulatory agent
    Patent number: 7691804
    Abstract: A novel receptor in the TNF family is provided: BAFF-R. Chimeric molecules and antibodies to BAFF-R and methods of use thereof are also provided.
    Type: Grant
    Filed: February 15, 2002
    Date of Patent: April 6, 2010
    Assignees: Biogen Idec MA Inc., Apoxis SA
    Inventors: Browning Jeffrey, Ambrose Christine, MacKay Fabienne, Tschopp Jurg, Schneider Pascal, Thompson Jeffrey
  • METHOD FOR THE TREATMENT OF GOUT OR PSEUDOGOUT
    Publication number: 20090022704
    Abstract: The present invention relates to a new method, and the process to manufacture a medicament, for treating gout or pseudogout, comprising administering an effective amount of inhibitors blocking IL-1 or its maturation by the NALP3 inflammasome.
    Type: Application
    Filed: January 8, 2007
    Publication date: January 22, 2009
    Applicant: APOXIS SA
    Inventors: Virginie Petrilli, Fabio Martinon, Jurg Tschopp, Thibault De Smedt
  • Method to Reduce Hepatoxicity of Fas-Mediated Apoptosis-Inducing Agents
    Publication number: 20080003226
    Abstract: The invention concerns a method to prevent or reduce adverse effects on liver of a patient treated with a Fas-mediated apoptosis-inducing agent, the method comprising the administration of a product preventing TNF receptors-mediated apoptosis of the liver cells.
    Type: Application
    Filed: May 27, 2005
    Publication date: January 3, 2008
    Applicant: APOXIS SA
    Inventors: Marc Dupuis, Stephane Demotz, Rene Goedkoop
  • Methods of treating a tumor that expresses APRIL by administering BCMA
    Patent number: 7276241
    Abstract: A novel receptor in the TNF family is provided: APRIL-R. Chimeric molecules and antibodies to APRIL-R and methods of use thereof are also provided.
    Type: Grant
    Filed: April 2, 2002
    Date of Patent: October 2, 2007
    Assignees: Biogen Idec MA Inc., Apoxis SA
    Inventors: Pascal Schneider, Jeffrey Thompson, Teresa Cachero, Christine Ambrose, Paul Rennert
  • METHOD FOR THE TREATMENT OF GOUT OR PSEUDOGOUT
    Publication number: 20070161559
    Abstract: The present invention relates to a new method, and the process to manufacture a medicament, for treating gout or pseudogout, comprising administering an effective amount of inhibitors blocking IL-1 or its maturation by the NALP3 inflammasome.
    Type: Application
    Filed: October 9, 2006
    Publication date: July 12, 2007
    Applicant: APOXIS SA
    Inventors: Virginie Petrilli, Fabio Martinon, Jurg Tschopp, Thibaut De Smedt
  • Methods of treatment by administering an anti-BCMA antibody
    Patent number: 7083785
    Abstract: A novel receptor in the TNF family is provided: BAFF-R. Chimeric molecules and antibodies to BAFF-R and methods of use thereof are also provided.
    Type: Grant
    Filed: February 15, 2002
    Date of Patent: August 1, 2006
    Assignees: Biogen Idcc MA Inc., Apoxis SA
    Inventors: Jeffrey Browning, Christine Ambrose, Fabienne MacKay, Jurg Tschopp, Pascal Schneider, Jeffrey Thompson